Simplex Trading’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-100
Closed -$3.27K – 9464
2025
Q4
$3.27K Hold
100
– – ﹤0.01% 7643
2025
Q3
$3K Sell
100
-39,800
-100% -$1.27M ﹤0.01% 8502
2025
Q2
$1.12M Buy
39,900
+39,000
+4,333% +$1.05M ﹤0.01% 2664
2025
Q1
$22K Sell
900
-15,300
-94% -$387K ﹤0.01% 6502
2024
Q4
$445K Buy
16,200
+11,600
+252% +$323K ﹤0.01% 3669
2024
Q3
$132K Buy
4,600
+3,500
+318% +$95.3K ﹤0.01% 4943
2024
Q2
$27K Hold
1,100
– – ﹤0.01% 6635
2024
Q1
$35K Sell
1,100
-13,900
-93% -$517K ﹤0.01% 6602
2023
Q4
$609K Sell
15,000
-11,400
-43% -$420K ﹤0.01% 3492
2023
Q3
$912K Buy
26,400
+10,200
+63% +$397K ﹤0.01% 2759
2023
Q2
$658K Sell
16,200
-45,400
-74% -$1.85M ﹤0.01% 3023
2023
Q1
$2.38M Buy
61,600
+21,700
+54% +$892K ﹤0.01% 1798
2022
Q4
$1.77M Buy
39,900
+25,200
+171% +$1.06M ﹤0.01% 1966
2022
Q3
$626K Sell
14,700
-700
-5% -$35.9K ﹤0.01% 3202
2022
Q2
$859K Sell
15,400
-11,900
-44% -$706K ﹤0.01% 2792
2022
Q1
$1.69M Buy
27,300
+8,200
+43% +$502K ﹤0.01% 2283
2021
Q4
$1.05M Sell
19,100
-8,600
-31% -$449K ﹤0.01% 2789
2021
Q3
$1.94M Hold
27,700
– – ﹤0.01% 2187
2021
Q2
$1.91M Buy
27,700
+27,471
+11,996% +$2.1M ﹤0.01% 2227
2021
Q1
$1.76M Buy
+229
New +$21.1K ﹤0.01% 1750
2020
Q4
– Sell
-11
Closed -$156K – 8582
2020
Q3
$156K Sell
11
-183
-94% -$30.5K ﹤0.01% 4404
2020
Q2
$3.83M Sell
194
-151
-44% -$31.3K 0.01% 1023
2020
Q1
$6.76M Buy
345
+223
+183% +$48K 0.01% 555
2019
Q4
$2.52M Buy
122
+9
+8% +$1.66K 0.01% 1277
2019
Q3
$1.72M Buy
113
+69
+157% +$11.3K ﹤0.01% 1454
2019
Q2
$567K Sell
44
-333
-88% -$39.5K ﹤0.01% 2453
2019
Q1
$4.44M Buy
377
+376
+37,600% +$37.9K 0.01% 759
2018
Q4
$9K Sell
1
-11
-92% -$1.12K ﹤0.01% 5898
2018
Q3
$134K Buy
+12
New +$1.27K ﹤0.01% 4108
2018
Q2
– Sell
-5
Closed -$11K – 7534
2018
Q1
$11K Buy
+5
New +$539 ﹤0.01% 3950

Other funds holding LKFT

Simplex Trading's LKFT Position: Q2 2026 in Review

Simplex Trading increased its Lakefront Biotherapeutics American Depositary Shares (LKFT) stake by 15% in Q2 2026, buying an estimated $31.1K and bringing the position to 8,323 shares worth $250K. The position accounts for ﹤0.01% of the portfolio, ranked #4443.

Simplex Trading first reported a position in LKFT in Q2 2017 and has held it in 19 quarters since. The position peaked at $3.72M in Q2 2020. 76 funds tracked by Wall St. Rank hold LKFT as of Q2 2026.

  • Simplex Trading held 8,323 shares of Lakefront Biotherapeutics American Depositary Shares worth $250K as of Q2 2026.
  • Simplex Trading bought 1,096 Lakefront Biotherapeutics American Depositary Shares shares in Q2 2026, an estimated $31.1K.
  • Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #4443 holding.
  • Simplex Trading first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q2 2017 and has held it in 19 quarters since.
  • Simplex Trading's Lakefront Biotherapeutics American Depositary Shares position peaked at $3.72M in Q2 2020.
  • 76 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.